IMVARIA has gained 510(k) clearance from the US Food and Drug Administration (FDA) for its AI-powered healthcare tool, ...

Mayo Clinic today unveiled separate groundbreaking collaborations with Microsoft Research and with Cerebras Systems in the field of generative artificial intelligence (AI), designed to personalize ...

It marks one of the largest deals for the medical technology company since GE HealthCare was spun off from General Electric.

The pharma giant is partnering with software firms to imagine new drugs, find targets, and design clinical trials ...

The model is the first of its kind to use multiple types of imaging and language-based data to assess a cancer patient's ...

A groundbreaking study led by Nobel Laureate David Baker and Timothy Patrick Jenkins introduces innovative, computationally ...

In 2024, the FDA issued two significant guidance documents on Predetermined Change Control Plans (PCCPs), formalizing a ...

Oakmark Funds, advised by Harris Associates, released its “Oakmark Select Fund” fourth quarter 2024 investor letter. A copy ...

Aaron Hudy, GE HealthCare U.S. and Canada President, West Central Region, said his company’s technology can reduce patients’ ...

In this article, I share my take on the transformative potential of AI and ML in the modern care delivery process.

In a changing political and economic landscape, here are 16 firms that could have a breakout year.

A new strategic plan provides a roadmap for leveraging AI use for the benefit of older adults, including in the provision of ...